Concepedia

Magdalena M. Szewczyk

MM

46

Publications

3.2K

Citations

32

H-Index

1991

Active since

Affiliations

University of Toronto(Current)

Structural Genomics Consortium

Princess Margaret Cancer Centre

Icahn School of Medicine at Mount Sinai

Ontario Institute for Cancer Research

Magdalena M. Szewczyk is an author at University of Toronto specializing in medicine, molecular biology, and natural sciences.

ORCID

Top concepts

Publications per year

1991–2024

46

Publications

46

A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases

Mohammad S. Eram, Yudao Shen, Magdalena M. Szewczyk et al. · ACS Chemical Biology · 2015 · 280 citations · Full text

, , +23

Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation

Jia Yi Fong, Luca Pignata, Pierre-Alexis Goy et al. · Cancer Cell · 2019 · 270 citations · Full text

, , +13

The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex

Yupeng He, Sujatha Selvaraju, Michael L. Curtin et al. · Nature Chemical Biology · 2017 · 229 citations · Full text

, , +7

LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity

Zahid Bonday, Guillermo S. Cortez, Michael J. Grogan et al. · ACS Medicinal Chemistry Letters · 2018 · 179 citations · Full text

TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma

Kazuhide Nakayama, Magdalena M. Szewczyk, Carlo dela Seña et al. · Oncotarget · 2018 · 135 citations · Full text

Rows per page

1–5 of 46